vorinostat has been researched along with Pemphigoid, Bullous in 2 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Pemphigoid, Bullous: A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchard, G | 1 |
| Solly, F | 1 |
| Basset, V | 1 |
| Fontao, L | 1 |
| Blanchard, M | 1 |
| Guenova, E | 1 |
| Gardner, JM | 1 |
| Evans, KG | 1 |
| Goldstein, S | 1 |
| Kim, EJ | 1 |
| Vittorio, CC | 1 |
| Rook, AH | 1 |
2 other studies available for vorinostat and Pemphigoid, Bullous
| Article | Year |
|---|---|
Vorinostat for treatment-refractory bullous pemphigoid.
Topics: Humans; Immunoglobulin G; Pemphigoid, Bullous; Vorinostat | 2023 |
Vorinostat for the treatment of bullous pemphigoid in the setting of advanced, refractory cutaneous T-cell lymphoma.
Topics: Antibodies, Anti-Idiotypic; Antineoplastic Agents; Diagnosis, Differential; Dose-Response Relationsh | 2009 |